Carysil Limited

Report azionario BSE:524091

Capitalizzazione di mercato: ₹34.3b

Carysil Crescita futura

Criteri Future verificati 3/6

Carysil prevede che gli utili e i ricavi cresceranno rispettivamente di 17.4% e 15.5% all'anno. Si prevede che l'EPS crescerà di 17.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.4% in 3 anni.

Informazioni chiave

17.4%

Tasso di crescita degli utili

17.35%

Tasso di crescita dell'EPS

Building crescita degli utili21.3%
Tasso di crescita dei ricavi15.5%
Rendimento futuro del capitale proprio17.43%
Copertura analitica

Low

Ultimo aggiornamento22 May 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Aggiornamento narrativa • Jun 18

524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance

Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.
Aggiornamento narrativa • Jun 02

524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside

Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.
Aggiornamento narrativa • May 17

524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside

Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).
Aggiornamento narrativa • Apr 28

524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside

Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.
Aggiornamento narrativa • Apr 12

524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside

Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Aggiornamento narrativa • Mar 28

524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.
Aggiornamento narrativa • Mar 11

524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Aggiornamento narrativa • Feb 25

524091: Upcoming Results And Steady Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.
Aggiornamento narrativa • Feb 11

524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside

Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Aggiornamento narrativa • Jan 27

524091: Steady Outlook And Upcoming Results Date Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.
Aggiornamento narrativa • Jan 10

524091: Steady Assumptions And Upcoming Results Will Support Future Upside

Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.
Aggiornamento narrativa • Dec 15

524091: Capacity Expansion Will Drive Future Earnings Momentum

Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
Aggiornamento narrativa • Dec 01

524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum

Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
Aggiornamento narrativa • Nov 16

524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook

Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
Aggiornamento narrativa • Aug 18

Global Kitchen Upgrades And Market Expansion Will Transform Industry

Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
User avatar
Nuova narrativa • Feb 18

Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions

Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.

Previsioni di crescita degli utili e dei ricavi

BSE:524091 - Stime future degli analisti e dati finanziari passati (INR Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
3/31/202812,6611,3904911,2443
3/31/202711,1001,1504761,1481
3/31/20269,240982-281,087N/A
12/31/20258,944897N/AN/AN/A
9/30/20258,750811203817N/A
6/30/20258,414707N/AN/AN/A
3/31/20258,156637129602N/A
12/31/20248,019608N/AN/AN/A
9/30/20247,868635-1,289-452N/A
6/30/20247,433622N/AN/AN/A
3/31/20246,838579-397534N/A
12/31/20236,388548N/AN/AN/A
9/30/20235,886515207812N/A
6/30/20235,642453N/AN/AN/A
3/31/20235,939524133712N/A
12/31/20225,872564N/AN/AN/A
9/30/20225,77561628737N/A
6/30/20225,577700N/AN/AN/A
3/31/20224,839648-256516N/A
12/31/20214,456614N/AN/AN/A
9/30/20214,05156344659N/A
6/30/20213,613480N/AN/AN/A
3/31/20213,09739189454N/A
12/31/20202,734300N/AN/AN/A
9/30/20202,591247243402N/A
6/30/20202,542209N/AN/AN/A
3/31/20202,762221102301N/A
12/31/20192,772223N/AN/AN/A
9/30/20192,662186N/A286N/A
6/30/20192,594187N/AN/AN/A
3/31/20192,516172N/A237N/A
12/31/20182,370155N/AN/AN/A
9/30/20182,226143N/AN/AN/A
6/30/20182,128126N/AN/AN/A
3/31/20181,965120N/A156N/A
12/31/20171,877117N/AN/AN/A
9/30/20171,806106N/AN/AN/A
6/30/20171,79299N/AN/AN/A
3/31/20171,81073N/A57N/A
12/31/20161,89490N/AN/AN/A
9/30/20161,907101N/AN/AN/A
6/30/20161,79694N/AN/AN/A
3/31/20161,738109N/A106N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 524091 ( 17.4% all'anno) è superiore al tasso di risparmio ( 6.9% ).

Guadagni vs Mercato: Si prevede che gli utili di 524091 ( 17.4% all'anno) cresceranno più rapidamente del mercato Indian ( 16.3% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 524091 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 524091 ( 15.5% all'anno) crescerà più rapidamente del mercato Indian ( 11.1% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 524091 ( 15.5% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 524091 sarà basso tra 3 anni ( 17.4 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/07/15 23:59
Prezzo dell'azione a fine giornata2026/07/15 00:00
Utili2026/03/31
Utili annuali2026/03/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Carysil Limited è coperta da 7 analisti. 3 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Rishab BothraAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Vyom ChhedaBP Wealth Management Private Limited